Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Profit After Tax: 2011-2024

Historic Profit After Tax for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $197.7 million.

  • Adma Biologics' Profit After Tax rose 1.45% to $36.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $209.4 million, marking a year-over-year increase of 207.41%. This contributed to the annual value of $197.7 million for FY2024, which is 800.00% up from last year.
  • Latest data reveals that Adma Biologics reported Profit After Tax of $197.7 million as of FY2024, which was up 800.00% from -$28.2 million recorded in FY2023.
  • In the past 5 years, Adma Biologics' Profit After Tax ranged from a high of $197.7 million in FY2024 and a low of -$75.7 million during FY2020.
  • Over the past 3 years, Adma Biologics' median Profit After Tax value was -$28.2 million (recorded in 2023), while the average stood at $34.5 million.
  • Data for Adma Biologics' Profit After Tax shows a peak YoY skyrocketed of 800.00% (in 2024) over the last 5 years.
  • Adma Biologics' Profit After Tax (Yearly) stood at -$75.7 million in 2020, then climbed by 5.41% to -$71.6 million in 2021, then increased by 8.02% to -$65.9 million in 2022, then surged by 57.15% to -$28.2 million in 2023, then skyrocketed by 800.00% to $197.7 million in 2024.